Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
3.200
+0.160 (5.26%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Tvardi Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -18.21 | -29.4 | -17.35 | -20.54 |
| Depreciation & Amortization | 0.1 | 0.1 | 0.1 | 0.09 |
| Loss (Gain) From Sale of Investments | -0.2 | - | -0.19 | -0.36 |
| Stock-Based Compensation | 1.4 | 0.32 | 0.31 | 0.25 |
| Other Operating Activities | -7.09 | 2.04 | 0.05 | 0.03 |
| Change in Accounts Payable | 0.92 | 5.57 | -1.01 | 2.2 |
| Change in Other Net Operating Assets | -0.41 | 3.07 | -2.95 | 0.47 |
| Operating Cash Flow | -23.5 | -18.31 | -21.04 | -17.87 |
| Capital Expenditures | - | - | - | -0.05 |
| Investment in Securities | -10.08 | - | 22.47 | -21.95 |
| Investing Cash Flow | -10.08 | - | 22.47 | -22 |
| Long-Term Debt Issued | - | 28.3 | - | - |
| Net Debt Issued (Repaid) | - | 28.3 | - | - |
| Issuance of Common Stock | 0.53 | 0.01 | 0 | 0 |
| Other Financing Activities | 22.17 | -1.3 | - | - |
| Financing Cash Flow | 22.7 | 27 | 0 | 0 |
| Net Cash Flow | -10.88 | 8.7 | 1.43 | -39.86 |
| Free Cash Flow | -23.5 | -18.31 | -21.04 | -17.92 |
| Free Cash Flow Per Share | -3.02 | -7.11 | -3.30 | -2.81 |
| Levered Free Cash Flow | -15.22 | -6.91 | -15.13 | - |
| Unlevered Free Cash Flow | -15.22 | -6.91 | -15.13 | - |
| Change in Working Capital | 0.51 | 8.64 | -3.96 | 2.67 |
Source: S&P Capital IQ. Standard template.
Financial Sources.